Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.31 BATS BZX Real-Time Price As of 11:39am ET |  +0.0281 / +9.97%Today’s Change | 0.25 Today|||52-Week Range 1.17 | -53.52% Year-to-Date |
Latest CYCC News | Press Releases
No recent news for Cyclacel Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.28 |
| Today’s open | 0.29 |
| Day’s range | 0.29 - 0.31 |
| Volume | 1,219 |
| Average volume (3 months) | 158,483 |
| Market cap | $3.5M |
Data as of 11:39am ET, 12/05/2023
Growth & Valuation
| Earnings growth (last year) | +11.09% |
| Earnings growth (this year) | +24.91% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTIXProtagenic Therapeut... | 0.00 | 0.00% |
| QLGNQualigen Therapeutic... | 0.00 | 0.00% |
| CPHIChina Pharma Holding... | +0.00 | +1.23% |
| ---- |
Data as of 11:08am ET, 12/05/2023
Financials
| Next reporting date | March 27, 2024 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Berkeley Heights, New Jersey |
Forecasts
